Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
75.6M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
31.2M
-
Shares change
-
+31.2M
-
Total reported value, excl. options
-
$677M
-
Value change
-
+$677M
-
Number of buys
-
43
-
Price
-
$21.68
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) as of Q3 2019
43 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q3 2019.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.2M shares
of 75.6M outstanding shares and own 41.29% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7.41M shares), Bain Capital Life Sciences Investors, LLC (7.28M shares), PERCEPTIVE ADVISORS LLC (3.22M shares), BVF INC/IL (2.84M shares), BOXER CAPITAL, LLC (2.08M shares), CITADEL ADVISORS LLC (1.32M shares), FMR LLC (1.11M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.05M shares), Samsara BioCapital, LLC (677K shares), and ArrowMark Colorado Holdings LLC (410K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.